Related Experiment Video
Updated: May 31, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
[Clinical application of botulinum toxin]
1Department of Neurology, Sakakibara Hakuho Hospital, Mie, Japan.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|July 13, 2011
Summary
Botulinum toxin (BoNT) is a versatile therapeutic agent used for various medical and cosmetic conditions. Research explores its efficacy, safety, and novel applications, including targeted delivery and non-injection methods.
Area of Science:
- Neurology
- Pharmacology
- Medical Aesthetics
Background:
- Botulinum toxin (BoNT) has a long history, proposed in 1822 and accepted therapeutically in the 1970s.
- Currently, BoNT is utilized globally for treating diverse medical ailments and cosmetic concerns.
- In Japan, specific formulations like Botox® and Botox Vista® are approved for conditions including blepharospasm, dystonia, spasticity, and glabellar lines.
Observation:
- BoNT provides symptomatic relief, with over 30% of cervical dystonia patients experiencing long-lasting remission.
- Ultrasound guidance is a valuable tool for BoNT injections, potentially superior to electromyography for certain muscles like obliquus capitis inferior, minimizing risks like vertebral artery injury.
- Beyond neuromuscular blockade, BoNT can alleviate pain and reduce glandular secretions.
Findings:
- BoNT exhibits axonal transport, moving centrally and to adjacent neurons via synapses (toxin jump), with a potential direct central action.
- While generally safe, rare serious adverse reactions can occur, and individual sensitivity variations may necessitate dose adjustments.
- Clinical applications are expanding, with ongoing trials for non-injection procedures and using BoNT as a delivery system for bioactive molecules.
Implications:
- The diverse applications of BoNT highlight its significance in modern medicine and aesthetics.
- Understanding BoNT's mechanism, transport, and safety profile is crucial for optimizing patient outcomes.
- Future research directions include exploring new BoNT types, chimera toxins, and innovative delivery methods for broader therapeutic benefits.
More Related Videos
Related Concept Videos
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:29Tetanus
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
01:12Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...